Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
7.1%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 0.91Close
$ 0.74 - $ 1.31 52-Week Range
Ticker Information
Ticker
CTSOCompany Name
CYTOSORBENTS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQCYTOSORBENTS CORP - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTSO - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 2.43M | 7.1% | $ 34.26M |
| 3/31/2025 | $ 2M | 5.78% | $ 34.54M |
| 12/31/2024 | $ 1.4M | 3.93% | $ 35.59M |
| 9/30/2024 | $ 827.13K | 2.19% | $ 37.74M |
| 6/30/2024 | $ 272.65K | 0.73% | $ 37.16M |
| 3/31/2024 | $ 101.37K | 0.28% | $ 36.69M |
| 12/31/2023 | $ 157.89K | 0.43% | $ 36.35M |
| 9/30/2023 | $ 51.91K | 0.14% | $ 37.07M |
| 6/30/2023 | $ -28.6K | -0.08% | $ 36.37M |
| 3/31/2023 | $ -61.4K | -0.17% | $ 35.45M |
Key Performance Insights, Last 5 Years
- CYTOSORBENTS CORP's latest trailing twelve months (TTM) Int. Exp. % stands at 3.16%.
- Over the past 5 years, CYTOSORBENTS CORP's average Int. Exp. % has been 1.49%.
- The median Int. Exp. % for CYTOSORBENTS CORP during this period was 0.58%
- CYTOSORBENTS CORP reached its highest Int. Exp. % over the past 5 years at 7.1%.
- The lowest Int. Exp. % recorded by CYTOSORBENTS CORP in the same timeframe -0.38%
CYTOSORBENTS CORP's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for CYTOSORBENTS CORP is calculated as follows: Int. Exp. [ $ 1.15M ] / Revenues [ $ 36.48M ]
(=) Int. Exp. % [ 3.16% ] CTSO - Interest Expense Margin, Last 5 years
-0.38%
Minimum
Dec 31, 2022
7.1%
Maximum
Jun 30, 2025
1.49%
Average
0.58%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |